Stéphane Grillet

Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: A prospective, open-label, parallel-cohort, single-center study

Cem Gabay, Michael Bel, Christophe Combescure et al. · Arthritis & Rheumatism · 2011 · 140 citations

Medicine, Immunology, Pharmacotherapy +17

Varicella-Zoster Immunization in Pediatric Liver Transplant Recipients: Safe and Immunogenic

Klara M. Posfay‐Barbe, Laure F. Pittet, C. Sottas et al. · American Journal of Transplantation · 2012 · 116 citations · Full text

Medicine, Immunology, Pediatrics +17

Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study

Angela Huttner, Sélidji Todagbé Agnandji, Christophe Combescure et al. · The Lancet Infectious Diseases · 2018 · 82 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

A dose-dependent plasma signature of the safety and immunogenicity of the rVSV-Ebola vaccine in Europe and Africa

Angela Huttner, Christophe Combescure, Stéphane Grillet et al. · Science Translational Medicine · 2017 · 64 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients

Bilal Mohty, Miquel Jordi Bel, Marija Vukicevic et al. · Haematologica · 2011 · 63 citations · Full text

Life Sciences, Immunology, Infectious Diseases +14